Literature DB >> 21088267

Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.

Hannah L F Cooper1, Don C Des Jarlais, Zev Ross, Barbara Tempalski, Brian Bossak, Samuel R Friedman.   

Abstract

OBJECTIVES: We examined relationships of spatial access to syringe exchange programs (SEPs) and pharmacies selling over-the-counter (OTC) syringes with New York City drug injectors' harm reduction practices.
METHODS: Each year from 1995 to 2006, we measured the percentage of 42 city health districts' surface area that was within 1 mile of an SEP or OTC pharmacy. We applied hierarchical generalized linear models to investigate relationships between these exposures and the odds that injectors (n = 4003) used a sterile syringe for at least 75% of injections in the past 6 months.
RESULTS: A 1-unit increase in the natural log of the percentage of a district's surface area within a mile of an SEP in 1995 was associated with a 26% increase in the odds of injecting with a sterile syringe; a 1-unit increase in this exposure over time increased these odds 23%. A 1-unit increase in the natural log of OTC pharmacy access improved these odds 15%.
CONCLUSIONS: Greater spatial access to SEPs and OTC pharmacies improved injectors' capacity to engage in harm reduction practices that reduce HIV and HCV transmission.

Entities:  

Mesh:

Year:  2010        PMID: 21088267      PMCID: PMC3093286          DOI: 10.2105/AJPH.2009.184580

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  43 in total

1.  Effects of distances to hospital and GP surgery on hospital inpatient episodes, controlling for needs and provision.

Authors:  R Haynes; G Bentham; A Lovett; S Gale
Journal:  Soc Sci Med       Date:  1999-08       Impact factor: 4.634

2.  Geographic proximity, policy and utilization of syringe exchange programmes.

Authors:  R Rockwell; D C Des Jarlais; S R Friedman; T E Perlis; D Paone
Journal:  AIDS Care       Date:  1999-08

3.  Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses.

Authors:  S J Hutchinson; A Taylor; D J Goldberg; L Gruer
Journal:  Addiction       Date:  2000-06       Impact factor: 6.526

4.  Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.

Authors:  C Des Jarlais; T Perlis; S R Friedman; T Chapman; J Kwok; R Rockwell; D Paone; J Milliken; E Monterroso
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 5.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

Authors:  D R Gibson; N M Flynn; D Perales
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

6.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

7.  Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.

Authors:  Benny J Kottiri; Samuel R Friedman; Alan Neaigus; Richard Curtis; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

8.  Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange.

Authors:  David R Gibson; Richard Brand; Kim Anderson; James G Kahn; Daniel Perales; Joseph Guydish
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

9.  Gender differences in HIV risk behaviors among young injectors and their social network members.

Authors:  Susanne B Montgomery; Justeen Hyde; Christine Johnson De Rosa; Louise Ann Rohrbach; Susan Ennett; S Marie Harvey; Michael Clatts; Ellen Iverson; Michele D Kipke
Journal:  Am J Drug Alcohol Abuse       Date:  2002       Impact factor: 3.829

10.  The impact of geographic accessibility on the intensity and quality of depression treatment.

Authors:  J Fortney; K Rost; M Zhang; J Warren
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

View more
  30 in total

1.  Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.

Authors:  Hannah L F Cooper; Brooke West; Sabriya Linton; Josalin Hunter-Jones; Maria Zlotorzynska; Ron Stall; Mary E Wolfe; Leslie Williams; H Irene Hall; Charles Cleland; Barbara Tempalski; Samuel R Friedman
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

2.  Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.

Authors:  Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

3.  Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.

Authors:  Natalie D Crawford; Silvia Amesty; Alexis V Rivera; Katherine Harripersaud; Alezandria Turner; Crystal M Fuller
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

4.  Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.

Authors:  Yanjia Cao; Kathleen Stewart; Eric Wish; Eleanor Artigiani; Marcella H Sorg
Journal:  J Subst Abuse Treat       Date:  2019-04-05

5.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

6.  Ethical considerations and potential threats to validity for three methods commonly used to collect geographic information in studies among people who use drugs.

Authors:  Abby E Rudolph; Angela Robertson Bazzi; Sue Fish
Journal:  Addict Behav       Date:  2016-05-17       Impact factor: 3.913

7.  Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.

Authors:  Britton A Gibson; Debarchana Ghosh; Jamie P Morano; Frederick L Altice
Journal:  Health Place       Date:  2014-05-21       Impact factor: 4.078

8.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.

Authors:  Sabriya L Linton; Hannah L F Cooper; Mary E Kelley; Conny C Karnes; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Catlainn Sionean; Elizabeth DiNenno; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  Ann Epidemiol       Date:  2016-08-08       Impact factor: 3.797

10.  Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research.

Authors:  Samuel R Friedman; Barbara Tempalski; Joanne E Brady; Brooke S West; Enrique R Pouget; Leslie D Williams; Don C Des Jarlais; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.